RAN BIOLINKS Collaborates with European Plotkin Institute for Vaccinology and The Human Immunome Project on an African-Initiated COVID-19 Vaccine Study in People Living with HIV
RAN BioLinks collaborates with EPIV and HIP on an African-led COVID-19 vaccine study in people living with HIV, advancing vaccine research and immunology.
RAN BIOLINKS is pleased to announce its collaboration with Arnaud Marchant's team at the European Plotkin Institute for Vaccinology at the Université libre de Bruxelles (ULB) in Belgium and the Human Immunome Project (HIP), focusing on an African-initiated COVID-19 trial. This study marks a crucial step forward in understanding vaccine responses, particularly in people living with HIV within the African context.
RAN BIOLINKS is proud to provide scientific support in collaboration with the team at the Université libre de Bruxelles during the analysis phase of this study. Continuing its commitment to contributing to healthcare evolution through innovative data management solutions, RAN BIOLINKS remains at the forefront of supporting cutting-edge research initiatives.
ABOUT RANBIOLINKS
RAN BioLinks is a research accelerator company focused on assisting academia and industry increase research productivity. The RAN BioLinks team collaborates globally, empowering researchers and accelerating their research outcomes. With over 20 years of experience, RAN BioLinks provides research frameworks that combine operational systems, research implementation consulting, advanced analytics, biobanking platforms for clinical trials, data management services, automation tools, and expert support, enabling researchers to expedite their work.
ABOUT THE HUMAN IMMUNOME PROJECT
The Human Immunome Project (HIP) generates diverse immunological datasets at scale and builds publicly available AI models of the immune system to accelerate medical research and drug discovery, improve health, and decrease healthcare costs worldwide. HIP operates globally and is a registered nonprofit organization.
ABOUT THE EUROPEAN PLOTKIN INSTITUTE FOR VACCINOLOGY AT UNIVERSITÉ LIBRE DE BRUXELLES
The European Plotkin Institute for Vaccinology (EPIV) is a joint initiative of the Université libre de Bruxelles (ULB) and the University of Antwerp and is part of the pandemic preparedness plan of the Belgium Federal Government. The EPIV at ULB provides immunological and microbiological support for vaccine studies.
Links:
https://www.ranbiolinks.com;
https://www.humanimmunomeproject.org/,
https://www.epiv.eu
Be first to the news
Get RAN BioLinks announcements, product news and regulatory updates straight to your inbox.